Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis
about
Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.Canagliflozin: A Review in Type 2 Diabetes.Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy.SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice.
P2860
Effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of canagliflozin, a so ...... mellitus: a post hoc analysis
@en
Effects of canagliflozin, a so ...... mellitus: a post hoc analysis.
@nl
type
label
Effects of canagliflozin, a so ...... mellitus: a post hoc analysis
@en
Effects of canagliflozin, a so ...... mellitus: a post hoc analysis.
@nl
prefLabel
Effects of canagliflozin, a so ...... mellitus: a post hoc analysis
@en
Effects of canagliflozin, a so ...... mellitus: a post hoc analysis.
@nl
P2093
P2860
P1476
Effects of canagliflozin, a so ...... mellitus: a post hoc analysis
@en
P2093
Michael J Davies
Michael Pfeifer
Raymond R Townsend
Ujjwala Vijapurkar
P2860
P2888
P356
10.1186/S12933-017-0511-0
P407
P577
2017-02-27T00:00:00Z
P6179
1084251145